Dotbee.ai

Analysis JD Orgochem Limited (JDORGOCHEM)

5/26/2024

Analysis JD Orgochem Limited (JDORGOCHEM)

Analysis of JD Orgochem Limited (JDORGOCHEM)

JD Orgochem Limited has been showing a consistent increase in the closing price over the past few days, with the latest closing price at 12.04. The Relative Strength Index (RSI) indicator is at 73.30, indicating that the stock may be overbought.

The Moving Average Convergence Divergence (MACD) indicator is positive at 0.81, but the MACD line is below the signal line, suggesting a potential bearish signal. However, the MACD histogram is negative at -0.14, indicating a decrease in bullish momentum.

In terms of moving averages, the Simple Moving Average (SMA) is at 11.07, the Exponential Moving Average (EMA) is at 10.87, and the Weighted Moving Average (WMA) is at 11.46. The stock price is currently above all these moving averages, indicating a bullish trend.

Overall, while the stock has been performing well in terms of price increase, caution is advised due to the overbought RSI and the potential bearish signal from the MACD indicator. It would be advisable to monitor the stock closely for any reversal signals before making any trading decisions.

Balance Sheet

These are balance sheets. Here are the conclusions:

1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,755,000,000.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $217,350,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $302,083,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2023 at $73,812,000,000.
6. The company seems to be investing more in non-current assets over the years, which might indicate long-term growth strategies.
7. The increase in liabilities suggests that the company is relying more on external funding sources.
8. Shareholders' equity has not been increasing proportionally to total assets, which might indicate a decrease in ownership value over the years.

Cash Flow 💶

This is the cash flow statement. Here are some conclusions we can draw from the data:

1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.

Earnings estimate

Based on analysts' estimates for future quarterly and annual earnings per share:

1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, with a low estimate of $1.27 and a high estimate of $1.36. This shows growth compared to the EPS of $1.26 from the same quarter a year ago.

2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, with a low estimate of $1.44 and a high estimate of $1.63. This indicates an increase from the EPS of $1.46 from the same quarter last year.

3. For the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, with a low estimate of $6.43 and a high estimate of $6.92. This reflects growth compared to the EPS of $6.13 from the previous fiscal year.

4. Looking ahead to the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, with a low estimate of $6.40 and a high estimate of $7.90. This forecast suggests an increase from the EPS of $6.59 reported for the current fiscal year.

Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, with expected growth in both the upcoming quarters and fiscal years.

Revenue estimate

Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:

1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.

2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.

3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.

4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.

Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.

Growth estimates

Based on the consensus estimates provided:
- The company is expected to have a growth rate of 7.5% in the current year.
- The growth rate is projected to increase to 5.6% in the current quarter and further to 4.8% in the next quarter.
- Over the next year, the growth rate is expected to reach 9.7%.
- Looking ahead, the company is forecasted to have an annual growth rate of 11% over the next 5 years.
- However, when compared to the past 5 years where the company had an annual growth rate of 20.15%, the future growth rate is expected to be lower.

In summary, the company is expected to experience moderate growth in the near term, with a slightly higher growth rate projected for the next year and the next 5 years compared to the current and upcoming quarters.

Price target

The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD

Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price is $191.57, which is below the average and median forecast. Investors should consider these forecasts along with other factors when making investment decisions.

Earnings

The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. However, on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.

Main Statystic 🧠

The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.

1. Financials:
- Cash Flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance Sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit Margin: 26.306%
- Fiscal Year Ends: September 30, 2023
- Income Statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.44, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating Margin: 30.743%
- Return on Assets TTM: 22.073999%
- Return on Equity TTM: 147.25%

2. Stock Statistics:
- Short Ratio: 1.66
- Float Shares: 15,308,320,742
- Shares Short: 94,308,265
- Avg 10 Volume: 52,903,608
- Avg 90 Volume: 62,823,269
- Shares Outstanding: 15,334,099,968
- Percent Held by Insiders: 5.22%
- Percent Held by Institutions: 57.555%
- Short Percent of Shares Outstanding: 0.62%

3. Valuation Metrics:
- PEG Ratio: 26.213001
- Forward PE: 26.213001
- Trailing PE: 29.428572
- Enterprise Value: $2,948,462,018,560
- Price to Book MRQ: 39.181313
- Price to Sales TTM: 7.6151557
- Enterprise to EBITDA: 22.745
- Enterprise to Revenue: 7.726
- Market Capitalization: $2,906,118,684,672

4. Stock Price Summary:
- Beta: 1.264
- Day 50 MA: 173.6936
- Day 200 MA: 180.7906
- Fifty-Two Week Low: $164.08
- Fifty-Two Week High: $199.62
- Fifty-Two Week Change: 8.253%

5. Dividends and Splits:
- Payout Ratio: 14.93%
- Dividend Date: May 16, 2024
- Last Split Date: August 31, 2020
- Ex-Dividend Date: May 10, 2024
- Last Split Factor: 4-for-1 split
- Forward Annual Dividend Rate: $1
- 5-Year Average Dividend Yield: 0.73%
- Forward Annual Dividend Yield: 0.5266761603816345%
- Trailing Annual Dividend Rate: $0.97
- Trailing Annual Dividend Yield: 0.5108758755701854%

Income statement 💸

These are the revenues. Here are the conclusions:

1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite fluctuations in other financial metrics, such as net income and EBIT, the trend in revenue growth has been positive.
3. The company seems to be effectively generating sales and increasing its top line, which is a good sign for its overall financial health and market position.
4. It would be beneficial to further analyze the company's revenue streams, product lines, and market segments to understand the factors driving this consistent growth in sales.

MACD of JDORGOCHEM

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link